Active Ingredient Denosumab

Active Ingredient Details

What is Denosumab?

A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.

What is the usage for Denosumab?

Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone.

How many products in the NDC database contain Denosumab?

The NDC database has 23 products with the active ingredient Denosumab. The following table lists all the products that have this active ingredient.

NDC Products with Denosumab

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0078-1350	Proprietary Name:	Denosumab	Liquid		Novartis Pharmaceuticals Corporation	ACTIVE
0143-9165	Proprietary Name: Enoby	Denosumab-qbde	Injection	Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0143-9166	Proprietary Name: Xtrenbo	Denosumab-qbde	Injection	Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
43835-0053	Proprietary Name:	Denosumab	Injection		Novo Nordisk Production Belgium Sa	ACTIVE
55513-710	Proprietary Name: Prolia	Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
55513-730	Proprietary Name: Xgeva	Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
61314-228	Proprietary Name: Wyost	Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
61314-240	Proprietary Name: Jubbonti	Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
65219-668	Proprietary Name: Conexxence	Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
65219-670	Proprietary Name: Bomyntra	Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
65219-672	Proprietary Name: Bomyntra	Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
70121-2701	Proprietary Name: Oziltus	Denosumab-mobz	Injection, Solution	Subcutaneous	Amneal Pharmaceuticals Llc	ACTIVE
70121-2702	Proprietary Name: Boncresa	Denosumab-mobz	Injection, Solution	Subcutaneous	Amneal Pharmaceuticals Llc	ACTIVE
71851-008	Proprietary Name:	Denosumab-bnht	Injection		Wuxi Biologics Co., Ltd.	ACTIVE
72606-037	Proprietary Name: Stoboclo	Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-038	Proprietary Name: Osenvelt	Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-058	Proprietary Name: Denosumab-bmwo	Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-059	Proprietary Name: Denosumab-bmwo	Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
78206-193	Proprietary Name: Bildyos	Denosumab	Injection, Solution	Subcutaneous	Organon Llc	ACTIVE
78206-195	Proprietary Name: Bilprevda	Denosumab	Injection, Solution	Subcutaneous	Organon Llc	ACTIVE
83257-029	Proprietary Name: Bosaya	Denosumab-kyqq	Injection	Subcutaneous	Biocon Biologics Inc.	ACTIVE
83257-030	Proprietary Name: Aukelso	Denosumab-kyqq	Injection	Subcutaneous	Biocon Biologics Inc.	ACTIVE
83457-012	Proprietary Name: Ospomyv	Denosumab	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE